Koers MedX Health Corp. Toronto S.E.
Aandelen
MDX
CA5850901037
Geavanceerde medische apparatuur & technologie
Omzet 2022 | 511K 373K 342K | Omzet 2023 | 456K 333K 305K | Marktkapitalisatie | 15,72 mln. 11,49 mln. 10,51 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -5 mln. -3,65 mln. -3,34 mln. | Nettowinst (verlies) 2023 | -4 mln. -2,92 mln. -2,68 mln. | EV/omzet 2022 | 22,1 x |
Nettoschuld 2022 | 4,86 mln. 3,55 mln. 3,25 mln. | Nettoschuld 2023 | 5,71 mln. 4,17 mln. 3,82 mln. | EV/omzet 2023 | 47 x |
K/w-verhouding 2022 |
-1,25
x | K/w-verhouding 2023 |
-2,58
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 93,77% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Lockyer
CEO | Chief Executive Officer | - | 25-04-23 |
Director of Finance/CFO | - | 29-04-22 | |
Bill Mitoulas
IRC | Investor Relations Contact | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Hennigar
BRD | Director/Board Member | 84 | 19-11-01 |
Kenneth McKay
CHM | Chairman | - | 19-11-01 |
Stephen Lockyer
CEO | Chief Executive Officer | - | 25-04-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+4,57% | 212 mld. | |
+8,61% | 186 mld. | |
+26,34% | 151 mld. | |
+33,90% | 114 mld. | |
+2,17% | 65,57 mld. | |
+14,50% | 52,61 mld. | |
-3,30% | 46,8 mld. | |
-3,98% | 38,95 mld. | |
+6,66% | 37,64 mld. |